» Articles » PMID: 35142692

MicroRNA-101a-3p Mimic Ameliorates Spinal Cord Ischemia/reperfusion Injury

Overview
Date 2022 Feb 10
PMID 35142692
Authors
Affiliations
Soon will be listed here.
Abstract

miR-101a-3p is expressed in a variety of organs and tissues and plays a regulatory role in many diseases, but its role in spinal cord ischemia/reperfusion injury remains unclear. In this study, we established a rat model of spinal cord ischemia/reperfusion injury by clamping the aortic arch for 14 minutes followed by reperfusion for 24 hours. Results showed that miR-101a-3p expression in L4-L6 spinal cord was greatly decreased, whereas MYCN expression was greatly increased. Dual-luciferase reporter assay results showed that miR-101a-3p targeted MYCN. MYCN immunoreactivity, which was primarily colocalized with neurons in L4-L6 spinal tissue, greatly increased after spinal cord ischemia/reperfusion injury. However, intrathecal injection of an miR-101a-3p mimic within 24 hours before injury decreased MYCN, p53, caspase-9 and interleukin-1β expression, reduced p53 immunoreactivity, reduced the number of MYCN/NeuN-positive cells and the number of necrotic cells in L4-L6 spinal tissue, and increased Tarlov scores. These findings suggest that the miR-101a-3p mimic improved spinal ischemia/reperfusion injury-induced nerve cell apoptosis and inflammation by inhibiting MYCN and the p53 signaling pathway. Therefore, miR-101a-3p mimic therapy may be a potential treatment option for spinal ischemia/reperfusion injury.

Citing Articles

Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury.

Sweed E, Khodir S, Motawea S, El-Haron H, Mostafa B, Elkholy M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39937253 DOI: 10.1007/s00210-025-03851-3.


Elucidation of the mechanism of Zhenbao pills for the treatment of spinal cord injury by network pharmacology and molecular docking: A review.

Xu M, Zhang W, Xu S, Niu X, Wang L, Wang X Medicine (Baltimore). 2024; 103(7):e36970.

PMID: 38363936 PMC: 10869052. DOI: 10.1097/MD.0000000000036970.


Spinal Cord Injury: From MicroRNAs to Exosomal MicroRNAs.

Xu X, Liu R, Li Y, Zhang C, Guo C, Zhu J Mol Neurobiol. 2024; 61(8):5974-5991.

PMID: 38261255 DOI: 10.1007/s12035-024-03954-7.


Role of hypoxic exosomes and the mechanisms of exosome release in the CNS under hypoxic conditions.

Yang R, Li Z, Xu J, Luo J, Qu Z, Chen X Front Neurol. 2023; 14:1198546.

PMID: 37786863 PMC: 10541965. DOI: 10.3389/fneur.2023.1198546.


Regulation of rat HspB5/alphaB-Crystallin by microRNAs miR-101a-3p, miR-140-5p, miR-330-5p, and miR-376b-3p.

Bartelt-Kirbach B, Golenhofen N Cell Stress Chaperones. 2023; 28(6):787-799.

PMID: 37584866 PMC: 10746672. DOI: 10.1007/s12192-023-01371-8.


References
1.
Astolfi A, Vendemini F, Urbini M, Melchionda F, Masetti R, Franzoni M . MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia. Oncotarget. 2013; 5(1):120-30. PMC: 3960194. DOI: 10.18632/oncotarget.1337. View

2.
He X, Tan Z, Mou Q, Liu F, Liu S, Yu C . microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma. Clin Cancer Res. 2016; 23(11):2905-2918. DOI: 10.1158/1078-0432.CCR-16-1591. View

3.
Saika R, Sakuma H, Noto D, Yamaguchi S, Yamamura T, Miyake S . MicroRNA-101a regulates microglial morphology and inflammation. J Neuroinflammation. 2017; 14(1):109. PMC: 5450088. DOI: 10.1186/s12974-017-0884-8. View

4.
Knoepfler P, Cheng P, Eisenman R . N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002; 16(20):2699-712. PMC: 187459. DOI: 10.1101/gad.1021202. View

5.
He F, Shi E, Yan L, Li J, Jiang X . Inhibition of micro-ribonucleic acid-320 attenuates neurologic injuries after spinal cord ischemia. J Thorac Cardiovasc Surg. 2015; 150(2):398-406. DOI: 10.1016/j.jtcvs.2015.03.066. View